Nurse Practitioner, Family · Terre Haute, IN
NPI
1508159096
Since 2011
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1429 No. 6th Street
Terre Haute, IN, 47807
Phone (812) 238-4402
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
852 services
Medicare patients, 2024
239
Average age 69
Drug cost, 2024
$2.4M
4,742 prescriptions
Company payments, 2025
$2,415
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephanie D Arnold was code 99214 (office e&m - established), 283 times for 174 patients. In total Stephanie D Arnold billed 852 services in 11 codes, and Medicare paid $34K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-02-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 283 | 174 | $71.53 | $20K |
| 83036 Blood Count | Office | 168 | 112 | $9.52 | $1,599 |
| 95251 Test - Miscellaneous | Office | 143 | 84 | $20.14 | $2,879 |
| 99213 Office E&M - Established | Office | 98 | 80 | $49.45 | $4,846 |
| 76536 Ultrasound - Nonspecific | Office | 17 | 17 | $60.40 | $1,027 |
| 99204 Office E&M - New | Office | 11 | 11 | $70.66 | $777 |
By year: 2022 $48K for 1,390 services; 2023 $48K for 2,142 services; 2024 $34K for 852 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 168 | 112 | $9.52 | $1,599 |
Medicare prescription drug claims, 2024
In 2024, the drug Stephanie D Arnold prescribed most often to Medicare patients was Levothyroxine Sodium, with 584 prescriptions and refills. In total Stephanie D Arnold wrote 4,742 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 584 | 1,078 | 149 | $12K |
| Mounjaro Tirzepatide | 505 | 555 | 100 | $575K |
| Ozempic Semaglutide | 311 | 413 | 81 | $387K |
| Metformin Hcl Generic | 204 | 442 | 54 | $1,173 |
| Metformin Hcl Er Metformin Hcl | 150 | 321 | 43 | $621 |
| Synthroid Levothyroxine Sodium | 150 | 313 | 38 | $13K |
| Tresiba Flextouch U-100 Insulin Degludec | 150 | 220 | 38 | $90K |
| Farxiga Dapagliflozin Propanediol | 145 | 175 | 32 | $100K |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 128 | 162 | 28 | $145K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 121 | 199 | 44 | $9,993 |
| Jardiance Empagliflozin | 97 | 132 | 21 | $77K |
| Insulin Lispro Generic | 86 | 102 | 26 | $8,558 |
| Humalog Insulin Lispro | 81 | 105 | 19 | $23K |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 78 | 149 | 24 | $44K |
| Tresiba Flextouch U-200 Insulin Degludec | 67 | 79 | 13 | $67K |
Brand drugs: 2,921 claims; generic drugs: 1,344 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephanie D Arnold $2,415 ($2,415 in general payments such as food, travel and fees) from 14 companies. The largest payer was Novo Nordisk Inc with $1,391.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 16 | $1,391 |
| Insulet Corporation PODD | 5 | $218 |
| Sequel Med Tech, LLC | 2 | $215 |
| Beta Bionics, Inc. BBNX | 1 | $125 |
| Tandem Diabetes Care, Inc. TNDM | 1 | $112 |
| Medtronic, Inc. MDT | 2 | $100 |
| Mannkind Corporation MNKD | 3 | $86.35 |
| Abbvie Inc. ABBV | 2 | $35.19 |
| Xeris Pharmaceuticals, Inc. | 2 | $34.41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28.72 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.